Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter einer 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NIKKEI-225 

WKN:  ISIN: XC0009692440 
NIKKEI-225
20.11.24
22:00 Uhr
38.279,70
+1,31
+0,00 %
1-Jahres-Chart
NIKKEI-225 Chart 1 Jahr
5-Tage-Chart
NIKKEI-225 5-Tage-Chart
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NIKKEI-225

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
07:19Cyberpunk 2077: Nachfolger statt PlayStation 5 Pro4
07:14Hedge fund Effissimo stirs speculation with its stake in Nissan Motor3
07:14Nissan urges U.K. to ease EV targets amid weak demand2
06:22SMBC's strategic vision for a sustainable future in Thailand5
06:01FAST RETAIL-DRS (06288): OVERSEAS REGULATORY ANNOUNCEMENT3
05:25Konkurrenz für japanische Autobauer: Honda, Nissan und Toyota verlieren immer mehr Marktanteile an China4
04:22Honda hopes to double EV driving range with solid-state batteries, R&D chief says2
04:22Itochu is a complex partner for 7-Eleven buyout4
04:18Honda Vietnam recalls nearly 2,700 CR-V Hybrid3
04:07FamilyMart launches 'Convenience Wear' clothing line in Taiwan2
03:55Honda has a plan to build solid-state batteries for EVs2
03:49Nomura Adds Risks of Crime in US Filing After Ex-Worker's Arrest4
02:59Kura Oncology Partners With Kyowa Kirin To Develop Ziftomenib For Acute Leukemias; Stock Drops1
00:31Kura stock slides 17% on Kyowa Kirin deal for ziftomenib2
MiKura Oncology to partner with Kyowa Kirin for blood cancer therapy3
MiNissui Achieves First Profit in Land-Based Shrimp Farming: A Step Toward Sustainable Aquaculture3
MiKura Oncology, Inc.: Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias2
MiKura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias242- Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in near-term milestone payments and opt-in right for solid tumors...
► Artikel lesen
MiHedge Fund Effissimo Stirs Speculation With Its Stake in Nissan3
MiToyota unveils new bZ7 EV in China, a surprisingly stylish electric sedan8
Seite:  Weiter >>